NMNAT-1 Antibody [H16N17] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat

Usage Information

Dilution
WB1:100-1:1000 IP1:100-1:200 IHC1:50-1:500 IF1:50-1:500

Application
WB, IP, IHC, IF, ELISA

Reactivity
Human, Mouse, Rat

Source
Mouse Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
32 kDa

Datasheet & SDS

Biological Description

Specificity
NMNAT-1 Antibody [H16N17] detects endogenous levels of total NMNAT-1 protein.

Clone
H16N17

Synonym(s)
NMN/NaMN adenylyltransferase 1, Nicotinamide-nucleotide adenylyltransferase 1 (NMN adenylyltransferase 1), Nicotinate-nucleotide adenylyltransferase 1, NMNAT1, NMNAT

Background
NMNAT-1 (nicotinamide mononucleotide adenylyltransferase 1) is the nuclear isoform of the NMNAT enzyme family and catalyzes a central step in NAD biosynthesis by converting nicotinamide mononucleotide or nicotinic acid mononucleotide and ATP into NAD⁺ or NaAD, positioning it as a key hub in nuclear NAD metabolism and redox cofactor homeostasis. The enzyme belongs to the NMNAT family of adenylyltransferases and forms a homo‑oligomeric complex with a conserved catalytic core that binds ATP and mononucleotide substrates, while N‑terminal sequences mediate nuclear targeting and integration into chromatin‑associated complexes. NMNAT‑1 localizes predominantly to the nucleoplasm, where it supports nuclear NAD⁺ pools required by NAD‑consuming enzymes such as PARP1 and sirtuins, and it participates in a nuclear salvage pathway together with NAMPT to regenerate NAD⁺ from nicotinamide and sustain continuous cycles of poly‑ADP‑ribosylation, deacetylation, and other NAD‑dependent reactions during transcription, DNA repair, and chromatin remodeling. Nuclear NAD⁺ generation by NMNAT‑1 contributes directly to ATP production in the nucleus in concert with PARP1, PARG, and NUDT5, and this ATP supply supports energy‑demanding chromatin remodeling events that accompany gene activation and rRNA transcription, linking NMNAT‑1 enzymatic activity to regulation of ribosomal biogenesis and nucleolar function. NMNAT‑1 also acts as a cofactor that directs PARP1 catalytic activity toward glutamate and aspartate residues on histones, coupling local NAD⁺ synthesis to site‑specific ADP‑ribosylation and thereby influencing chromatin structure, transcriptional competence, and DNA damage responses. In neuronal systems, NMNAT‑1 participates in axon maintenance pathways; its enzymatic activity protects axons against degeneration triggered by mechanical or toxic insults, and NMNAT‑dependent neuroprotection associates with its chaperone‑like properties and ability to maintain neuronal homeostasis under stress. In the retina, NMNAT‑1 expression is essential for proper differentiation and survival of photoreceptor cells and supports retinal NAD⁺ metabolism and energy balance, and pathogenic loss‑of‑function mutations in NMNAT1 cause the LCA9 form of Leber congenital amaurosis characterized by severe early‑onset retinal degeneration.

Background

NMNAT-1 (nicotinamide mononucleotide adenylyltransferase 1) is the nuclear isoform of the NMNAT enzyme family and catalyzes a central step in NAD biosynthesis by converting nicotinamide mononucleotide or nicotinic acid mononucleotide and ATP into NAD⁺ or NaAD, positioning it as a key hub in nuclear NAD metabolism and redox cofactor homeostasis. The enzyme belongs to the NMNAT family of adenylyltransferases and forms a homo‑oligomeric complex with a conserved catalytic core that binds ATP and mononucleotide substrates, while N‑terminal sequences mediate nuclear targeting and integration into chromatin‑associated complexes. NMNAT‑1 localizes predominantly to the nucleoplasm, where it supports nuclear NAD⁺ pools required by NAD‑consuming enzymes such as PARP1 and sirtuins, and it participates in a nuclear salvage pathway together with NAMPT to regenerate NAD⁺ from nicotinamide and sustain continuous cycles of poly‑ADP‑ribosylation, deacetylation, and other NAD‑dependent reactions during transcription, DNA repair, and chromatin remodeling. Nuclear NAD⁺ generation by NMNAT‑1 contributes directly to ATP production in the nucleus in concert with PARP1, PARG, and NUDT5, and this ATP supply supports energy‑demanding chromatin remodeling events that accompany gene activation and rRNA transcription, linking NMNAT‑1 enzymatic activity to regulation of ribosomal biogenesis and nucleolar function. NMNAT‑1 also acts as a cofactor that directs PARP1 catalytic activity toward glutamate and aspartate residues on histones, coupling local NAD⁺ synthesis to site‑specific ADP‑ribosylation and thereby influencing chromatin structure, transcriptional competence, and DNA damage responses. In neuronal systems, NMNAT‑1 participates in axon maintenance pathways; its enzymatic activity protects axons against degeneration triggered by mechanical or toxic insults, and NMNAT‑dependent neuroprotection associates with its chaperone‑like properties and ability to maintain neuronal homeostasis under stress. In the retina, NMNAT‑1 expression is essential for proper differentiation and survival of photoreceptor cells and supports retinal NAD⁺ metabolism and energy balance, and pathogenic loss‑of‑function mutations in NMNAT1 cause the LCA9 form of Leber congenital amaurosis characterized by severe early‑onset retinal degeneration.

References
https://pubmed.ncbi.nlm.nih.gov/23737528/ https://pubmed.ncbi.nlm.nih.gov/23737528/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%